This section contains prescribing guidelines and information on:
- Safe Use of Valproate Policy
- The above policy provides advice and guidance for healthcare professionals to ensure the safe prescribing and dispensing of valproate for all patients across SWL. The policy must be used in conjunction with local standard operating procedures, organisational policies and the Medicines and Healthcare products Regulatory Agency (MHRA) Healthcare Professional Guide.
- ‘Valproate’ is used to mean oral sodium valproate, valproic acid and valproate semi sodium.
- Mental Health
- Dementia: Prescribing Medication
- Depression and Anxiety Treatment Guidelines
- Melatonin Prescribing Guidance for Children and Young People
- Neurology
- SWL Headache Pathway
- Headache Referral and Management Guideline in adults
- Episodic and Chronic Migraine SWL Drug Pathway
- Migraine: Primary care acute migraine prescribing guidelines for use in adults